Ophthalmology and Private Equity: Key Findings / 2020 Outlook
Our recently published white paper examined all core aspects of private equity's investment in ophthalmology practices and surgery centers from 2012 – 2019.
Our recently published white paper examined all core aspects of private equity's investment in ophthalmology practices and surgery centers from 2012 – 2019.
Many Physician-owners of specialty medical practices and surgery centers are considering their best "end-game" strategy for the business they have spent a lifetime building.
The 29th M&A Worldwide Rainmaker MIAMI Summit, held November 15-16 in Miami Beach’s famous Art Deco District on South Beach, included 112 people from 22 countries, including: Argentina, Belgium, Brazil, Canada, Croatia, the Czech Republic, Denmark, England, France, Germany, Guatemala, Hungary, Ireland, Japan, Mexico, the Netherlands, Poland, Portugal, Spain, Thailand, Turkey, and the United States.
It’s our pleasure to invite you to join us at ...
Recently my colleague Marco Chan shared an extraordinary story that puts a new slant on the public discussion about robotics, China, outsourcing and the future of jobs. According to this Bloomberg Business Week story, a Chinese manufacturer, Tianyuan Garments Co., is investing $20 million to open a plant in Little Rock that will utilize robots developed by a Georgia company, Software Automation, to manufacture T-Shirts at a cost of 33 cents per shirt. Each SEWBOT™ workline is capable of spitting out a T-Shirt every 26 seconds. Human workers don’t stand a chance against such competition, no matter how low a wage rate they are willing to accept.
Like the internet before it, the automation boom is gaining steam as costs come down and the technologies become more approachable for the average business. Here are just a few of the rapidly advancing technologies that have primed the coming explosion in automation.
With the economy on the rise again, an unlikely sector is reaping the benefits: Outpatient ambulatory surgery centers (ASC).
In this article, in addition to discussing biopharmaceutical developments of interest to the market, we will review some recent stroke rehabilitation strategies as well as the current definition of stroke symptoms and risk factors.